CRLF2 and acute lymphoblastic leukemia: In previous reports, late relapse results in poor outcomes among the pediatric BCP-ALL patients, especially those stratified in the intermediate risk group associated with high CRLF2 mRNA expression and CRLF2 rearrangements (for example, P2RY8-CRLF2 fusion) [15, 16].